FDA Inspection
Gadal Laboratories Inc.Gadal Laboratories Inc. – FDA Inspection, Feb 17, 2023
Record Details
This FDA Inspection record concerns Gadal Laboratories Inc., with an inspection on February 17, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d0f952a9-f2cc-4836-99f8-d784a9c1c4f9
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1197938
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- Warning Letter
Other FDA inspections of Gadal Laboratories Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 29, 2026 | Not classified | Florida District Office | Foodborne Biological Hazards |
| August 9, 2019 | VAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| April 28, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 23, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Gadal Laboratories Inc.
- FDA Inspection 1324124 - 2026-06-29
- FDA Inspection 1099170 - 2019-08-09
- FDA Inspection 976729 - 2016-04-28
- FDA Inspection 814857 - 2013-01-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.